1. The Prolyl Peptidases PRCP/PREP Regulate IRS-1 Stability Critical for Rapamycin-induced Feedback Activation of PI3K and AKT
- Author
-
Ricardo E. Perez, Lei Duan, Victor V. Levenson, Brian Danzer, Carl G. Maki, Guoguang Ying, and Zia Shariat-Madar
- Subjects
Cell signaling ,Proto-Oncogene Proteins c-akt ,Carboxypeptidases ,Biology ,Biochemistry ,Receptor tyrosine kinase ,Phosphatidylinositol 3-Kinases ,Enzyme activator ,chemistry.chemical_compound ,Cell Line, Tumor ,Humans ,Phosphatidylinositol ,skin and connective tissue diseases ,Molecular Biology ,Protein kinase B ,PI3K/AKT/mTOR pathway ,DNA Primers ,Sirolimus ,Base Sequence ,Serine Endopeptidases ,Cell Biology ,Enzyme Activation ,chemistry ,Insulin Receptor Substrate Proteins ,Cancer research ,biology.protein ,Phosphorylation ,Prolyl Oligopeptidases ,Signal Transduction - Abstract
The phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB/AKT)/mammalian target of rapamycin (mTOR) pathway conveys signals from receptor tyrosine kinases (RTKs) to regulate cell metabolism, proliferation, survival, and motility. Previously we found that prolylcarboxypeptidase (PRCP) regulate proliferation and survival in breast cancer cells. In this study, we found that PRCP and the related family member prolylendopeptidase (PREP) are essential for proliferation and survival of pancreatic cancer cells. Depletion/inhibition of PRCP and PREP-induced serine phosphorylation and degradation of IRS-1, leading to inactivation of the cellular PI3K and AKT. Notably, depletion/inhibition of PRCP/PREP destabilized IRS-1 in the cells treated with rapamycin, blocking the feedback activation PI3K/AKT. Consequently, inhibition of PRCP/PREP enhanced rapamycin-induced cytotoxicity. Thus, we have identified PRCP and PREP as a stabilizer of IRS-1 which is critical for PI3K/AKT/mTOR signaling in pancreatic cancer cells.
- Published
- 2014